Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Ann Hematol ; 98(12): 2781-2792, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31673775

ABSTRACT

Autologous stem cell transplantation (ASCT) combined with novel agents is the standard treatment for transplant-eligible, newly diagnosed myeloma (NDMM) patients. Lenalidomide is approved for maintenance after ASCT until progression, although the optimal duration of maintenance is unknown. In this trial, 80 patients with NDMM received three cycles of lenalidomide, bortezomib, and dexamethasone followed by ASCT and lenalidomide maintenance until progression or toxicity. The primary endpoint was the proportion of flow-negative patients. Molecular response was assessed if patients were flow-negative or in stringent complete response (sCR). By intention to treat, the overall response rate was 89%. Neither median progression-free survival nor overall survival (OS) has been reached. The OS at 3 years was 83%. Flow-negativity was reached in 53% and PCR-negativity in 28% of the patients. With a median follow-up of 27 months, 29 (36%) patients are still on lenalidomide and 66% of them have sustained flow-negativity. Lenalidomide maintenance phase was reached in 8/16 high-risk patients but seven of them have progressed after a median of only 6 months. In low- or standard-risk patients, the outcome was promising, but high-risk patients need more effective treatment approach. Flow-negativity with the conventional flow was an independent predictor for longer PFS.


Subject(s)
Lenalidomide/administration & dosage , Maintenance Chemotherapy , Multiple Myeloma , Stem Cell Transplantation , Adult , Aged , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Autografts , Bortezomib/administration & dosage , Dexamethasone/administration & dosage , Disease-Free Survival , Female , Finland , Humans , Male , Middle Aged , Multiple Myeloma/diagnosis , Multiple Myeloma/mortality , Multiple Myeloma/therapy , Survival Rate
2.
J Crit Care ; 43: 139-142, 2018 Feb.
Article in English | MEDLINE | ID: mdl-28898742

ABSTRACT

PURPOSE: We were interested in whether C-reactive protein (CRP) and procalcitonin (PCT) distinguish sepsis from non-septic controls and whether a combination of CRP, PCT, and neutrophil CD64 improves identification of sepsis in the intensive care unit (ICU). MATERIALS AND METHODS: We analyzed the CRP and PCT concentrations from 27 patients with sepsis and 15 ICU controls. In addition, CD64 on neutrophils was measured using quantitative flow cytometry. We present a multiple marker analysis for sepsis diagnostics combining neutrophil CD64, CRP, and PCT using post-test analysis. RESULTS: The CRP and PCT values separated sepsis and non-septic ICU patients. In post-test analysis, CRP provided a positive probability of 0.48 and a negative probability of 0.053 for sepsis in the ICU; while, the corresponding values were 0.35 and 0.0059, respectively, for PCT and 0.62 and 0.0013, respectively, for neutrophil CD64. When neutrophil CD64 was analyzed with PCT and CRP, the probabilities were 0.98 and <0.001, respectively. CONCLUSIONS: Neutrophil CD64 expression was superior to PCT and CRP for the identification of sepsis in ICU. Positive post-test probability for any combinations of simultaneously analyzed CRP, PCT and CD64 showed improved diagnostic accuracy for sepsis. This approach may be useful for guiding antibiotic treatment in ICU.


Subject(s)
C-Reactive Protein/metabolism , Calcitonin/metabolism , Neutrophils/metabolism , Receptors, IgG/metabolism , Sepsis/diagnosis , Aged , Biomarkers/metabolism , Case-Control Studies , Female , Flow Cytometry , Humans , Intensive Care Units , Male , Middle Aged , Probability , Sensitivity and Specificity , Sepsis/metabolism
3.
APMIS ; 125(6): 536-543, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28211096

ABSTRACT

The aim of the present study was to investigate whether expression of monocyte and lymphocyte surface molecules differs between patients with severe sepsis and non-septic patients treated in the intensive care unit (ICU). The expression of monocyte CD14, CD40, CD80 and HLA-DR, and lymphocyte CD69 were analyzed using quantitative flow cytometry on three consecutive days in 27 patients with severe sepsis and in 15 non-septic patients. Receiver operating characteristic analyses were performed and each corresponding area under the curve (AUC) was determined. The results showed that the expression levels of CD40 on monocytes and CD69 on CD4+ T cells and on natural killer (NK) cells were highest in patients with severe sepsis (p < 0.05). Monocyte CD40 and NK cell CD69 expression levels were higher in patients with severe sepsis and positive blood culture compared with those with negative blood culture (p < 0.05). The highest values of AUC for severe sepsis detection were 0.836 for CD40, 0.872 for CD69 on NK cells, and 0.795 for CD69 on CD4+ T cells. These findings suggest that monocyte CD40 and CD69 on NK cells and CD4+ T cells could prove useful for new approaches in the identification of severe sepsis in the ICU.


Subject(s)
Antigens, CD/analysis , Critical Illness , HLA-DR Antigens/analysis , Killer Cells, Natural/chemistry , Monocytes/chemistry , Sepsis/pathology , T-Lymphocytes/chemistry , Adult , Biomarkers/analysis , Female , Flow Cytometry , Humans , Male , Middle Aged , Prospective Studies , Sepsis/diagnosis
4.
J Clin Lab Anal ; 25(2): 118-25, 2011.
Article in English | MEDLINE | ID: mdl-21438005

ABSTRACT

Flow cytometric analysis of leukocyte surface antigens has been used to characterize infectious and septic processes in patients. We wanted to investigate how the sampling and processing temperature, the anticoagulant used, and the storage of the sample influence leukocyte immunophenotyping. Four blood samples, two using acid citrate dextrose and two using heparin as an anticoagulant, were taken from five intensive-care unit patients with severe sepsis and five healthy volunteers. The samples were collected, stored, and processed either at +4°C or at room temperature (RT). The samples were processed for flow cytometric analysis within 1 hr of collection or after 6 or 24 hr storage. The surface antigens of interest were neutrophilic CD11b and CD64, monocytic CD11b, CD14, CD40, CD64, CD80 and HLA-DR, and lymphocytic CD69 (separately in CD4+ and CD8+ T cells, B cells, and natural killer cells). The fluorescence intensities were higher at RT than at +4°C. During storage the intensities increased at RT, but at +4°C there were only minor changes. The effects were similar with both anticoagulants studied. According to our results, flow cytometric analysis of leukocyte surface antigen expressions should be performed using +4°C temperature throughout the process and within 6 hr.


Subject(s)
Antigens, CD/immunology , Flow Cytometry/methods , Sepsis/immunology , Adult , Aged , Cold Temperature , Cryopreservation , Female , Humans , Male , Middle Aged , Sepsis/diagnosis , Time Factors , Young Adult
5.
J Biol Chem ; 279(23): 24521-9, 2004 Jun 04.
Article in English | MEDLINE | ID: mdl-15047704

ABSTRACT

Collagen XVII/BP180, an epithelial adhesion molecule, belongs to the group of collagenous transmembrane proteins, which are characterized by ectodomain shedding. We recently showed that ADAMs can cleave collagen XVII, but also that furin participates in this process (Franzke, C. W., Tasanen, K., Schäcke, H., Zhou, Z., Tryggvason, K., Mauch, C., Zigrino, P., Sunnarborg, S., Lee, D. C., Fahrenholz, F., and Bruckner-Tuderman, L. (2002) EMBO J. 21, 5026-5035). To define the cleavage region in the juxtamembranous NC16A linker domain and assess its structure and requirements for shedding, we constructed deletion mutants of the NC16A domain, expressed them in COS-7 cells, and analyzed their structural integrity and shedding behavior. A mutant lacking the furin consensus sequence was shed in a normal manner, demonstrating that furin does not cleave collagen XVII but rather activates ADAMs (a disintegrin and metalloproteinase). Large deletions of the NC16A domain prevented shedding, and analysis of defined smaller deletions pointed to the stretch of amino acid residues 528-547 as important for sheddase recognition and cleavage. Secondary protein structure predictions showed that deletion of this stretch resulted in an NC16A domain with a positive net charge and an amphipathic alpha-helix, which can cause conformational changes in the collagen XVII homotrimer. Assessment of triple-helix folding of the mutants revealed a lower thermal stability of all non-shed variants than of wild-type collagen XVII or the shed mutants. In contrast, deletion of the putative nucleation site for triple-helix folding of collagenous transmembrane proteins did not affect folding of collagen XVII. The data indicate that the conformation of the NC16A domain and steric availability of the cleavage site influence shedding and is important for folding of collagen XVII.


Subject(s)
Autoantigens/chemistry , Cell Membrane/metabolism , Collagen/chemistry , Non-Fibrillar Collagens , ADAM Proteins , ADAM10 Protein , Amino Acid Motifs , Amino Acid Sequence , Amyloid Precursor Protein Secretases , Animals , COS Cells , DNA, Complementary/metabolism , Dimerization , Disintegrins/chemistry , Furin/chemistry , Gene Deletion , Glycosylation , Humans , Membrane Proteins/chemistry , Metalloendopeptidases/chemistry , Molecular Sequence Data , Mutation , Precipitin Tests , Protein Conformation , Protein Folding , Protein Structure, Secondary , Protein Structure, Tertiary , RNA Interference , Temperature , Time Factors , Transfection , Collagen Type XVII
SELECTION OF CITATIONS
SEARCH DETAIL
...